BG104555A - Polyethoxylated castor oil, method for its making and application - Google Patents

Polyethoxylated castor oil, method for its making and application

Info

Publication number
BG104555A
BG104555A BG104555A BG10455500A BG104555A BG 104555 A BG104555 A BG 104555A BG 104555 A BG104555 A BG 104555A BG 10455500 A BG10455500 A BG 10455500A BG 104555 A BG104555 A BG 104555A
Authority
BG
Bulgaria
Prior art keywords
castor oil
polyethoxilated
low
content
making
Prior art date
Application number
BG104555A
Other languages
Bulgarian (bg)
English (en)
Inventor
Aleksandr Nikolayev
Sayeed Fakrul
Rupa IYAR
Michell GARBER
Robert BUTTERHOF
Todd HOYER
Marvin Samson
Original Assignee
Schein Pharmaceutical, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schein Pharmaceutical, Inc filed Critical Schein Pharmaceutical, Inc
Publication of BG104555A publication Critical patent/BG104555A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG104555A 1997-12-24 2000-06-23 Polyethoxylated castor oil, method for its making and application BG104555A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/998,306 US5925776A (en) 1997-12-24 1997-12-24 Polyethoxylated castor oil, process of making the same and formulations thereof
PCT/US1998/008521 WO1999033780A1 (en) 1997-12-24 1998-04-28 Novel polyethoxylated castor oil, process of making the same and formulations thereof

Publications (1)

Publication Number Publication Date
BG104555A true BG104555A (en) 2001-08-31

Family

ID=25545031

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104555A BG104555A (en) 1997-12-24 2000-06-23 Polyethoxylated castor oil, method for its making and application

Country Status (14)

Country Link
US (1) US5925776A (ja)
EP (1) EP1045825A1 (ja)
JP (1) JP2003518140A (ja)
KR (1) KR20010033607A (ja)
AU (1) AU7261798A (ja)
BG (1) BG104555A (ja)
CA (1) CA2315853A1 (ja)
EA (1) EA200000569A1 (ja)
HU (1) HUP0100211A2 (ja)
IL (1) IL136942A0 (ja)
NO (1) NO20003206L (ja)
PL (1) PL341757A1 (ja)
SK (1) SK9682000A3 (ja)
WO (1) WO1999033780A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100330373B1 (ko) * 1996-05-28 2002-11-07 주식회사한국신약 탁솔을 함유한 주사용 약제 조성물
KR19990075621A (ko) * 1998-03-23 1999-10-15 임성주 경사 평판형 배양조
DE19983660T1 (de) 1998-10-20 2001-09-13 Ben Venue Lab Inc Verfahren zur Aufreinigung von Lösungsmitteln, die bei der Herstellung von pharmazeutischen Zusammensetzungen nützlich sind
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
AU776993B2 (en) * 2000-01-20 2004-09-30 Baker Norton Pharmaceuticals, Inc. Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
JP2004536026A (ja) * 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
DE60136648D1 (de) 2000-12-05 2009-01-02 Los Angeles Childrens Hospital Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
EP1461056A4 (en) * 2001-11-26 2006-01-25 Supergen Inc PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLATED CICRIC OIL IN PHARMACEUTICAL COMPOSITIONS
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
CZ294371B6 (cs) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
EP1624896B1 (de) * 2003-05-19 2009-07-29 Ebewe Pharma Ges.m.b.H. Nfg. KG Verfahren zur herstellung einer stabilen injizierbaren formulierung von paclitaxel
US20050016926A1 (en) * 2003-07-24 2005-01-27 Dabur Research Foundation Stabilized formulation
US20050256097A1 (en) * 2004-05-11 2005-11-17 Kosan Biosciences, Inc. Pharmaceutical solution formulations containing 17-AAG
JP2009511643A (ja) * 2005-06-21 2009-03-19 ザ・コカ−コーラ・カンパニー エッセンシャル・オイルから汚染物質を除去するための方法
PL3311805T3 (pl) 2005-08-31 2020-07-27 Abraxis Bioscience, Llc Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe
EP1998808A1 (en) * 2006-02-21 2008-12-10 Dabur Pharma Limited Stable pharmaceutical composition of taxanes
EP2777691A1 (en) * 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
US5407683A (en) * 1990-06-01 1995-04-18 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel

Also Published As

Publication number Publication date
EA200000569A1 (ru) 2001-04-23
HUP0100211A2 (hu) 2001-06-28
NO20003206L (no) 2000-08-22
SK9682000A3 (en) 2000-12-11
NO20003206D0 (no) 2000-06-21
KR20010033607A (ko) 2001-04-25
JP2003518140A (ja) 2003-06-03
IL136942A0 (en) 2001-06-14
US5925776A (en) 1999-07-20
PL341757A1 (en) 2001-05-07
CA2315853A1 (en) 1999-07-08
AU7261798A (en) 1999-07-19
WO1999033780A1 (en) 1999-07-08
EP1045825A1 (en) 2000-10-25

Similar Documents

Publication Publication Date Title
BG104555A (en) Polyethoxylated castor oil, method for its making and application
IL98712A0 (en) 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
HK1004663A1 (en) Formulations and methods for reducing skin irritation
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
CA2371896A1 (en) Method of increasing the content of flavonoids and phenolic substances in plants
BR9801736A (pt) Processo de produção de dextrano.
BG101232A (en) Bactericides
CA2180846A1 (en) Method of treating disorders of the eye
EP0318233A3 (en) Improvements in or relating to serotonin and norepinephrine uptake inhibitors
HU912271D0 (en) Process for the production of bis/4-(2,6-dialkyl)phenol/-silane derivatives with antiatherosclerotic effect
TW272128B (ja)
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
WO1996004886A3 (en) Gelling compositions comprising optically enriched gellants
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
HUT42320A (en) Process for preparing colloidal compositions comprising primycin
WO1998025741A3 (en) Wood preservation utilizing polymeric phenol sulfide
IL105947A (en) Preparation of melanin in fluorocarbons for topical use and its production
MY129632A (en) Wood preservative formulations
HUT70614A (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine compositions containing them as active component
EA199800819A1 (ru) Способ лечения биполярного расстройства
IL139303A0 (en) Treatment of arthritis and other similar conditions
CA2220281A1 (en) A phospholipidic composition, method for the production of such a composition and its use
ES2021334B3 (es) Composiciones de caucho que contienen derivados aminicos del 1,3,4-triadiazol.